KindredBio named AAHA Advantage's new vendorApril 25, 2019Kindred Biosciences has been named American Animal Hospital Association (AAHA) Advantage's newest vendor. As part of the deal, the biopharmaceutical company will provide marketing and education funds to enhance AAHA's existing educational programs and resources. "At KindredBio, we support veterinary science at every level, whether it's in the laboratory where we develop innovative technologies or in the exam room where veterinarians put science into action," says KindredBio president and chief operating officer, Denise Bevers. "As such, we are proud to join forces with the AAHA."
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
